Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on incfII plasmids among escherichia coli isolates from pets in China

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 2135-2138

  Hou, Jianxia ^a   Huang, Xianhui ^a   Deng, Yuting ^a   He, Liangying ^a   Yang, Tong ^a   Zeng, Zhenling ^a   Chen, Zhangliu ^a   Liu, Jian Hua ^a  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE CTX M; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; FOSFOMYCIN; STREPTOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PET ANIMAL; PLASMID; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CATS; CHINA; CONJUGATION, GENETIC; DOGS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FECES; FOSFOMYCIN; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PETS; PLASMIDS; POLYMERASE CHAIN REACTION;

EID: 84863337710     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05104-11     Document Type: Article

References (27)

1. Carattoli A, et al. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. (Pubitemid 41597366)
2. Chen L, et al. 2007. Emergence of RmtB methylase-producing Escherichia coli and Enterobacter cloacae isolates from pigs in China. J. Antimicrob. Chemother. 59:880-885. (Pubitemid 47073358)
3. Chislett RJ, White G, Hills T, Turner DP. 2010. Fosfomycin susceptibility among extended-spectrum β-lactamase-producing Escherichia coli in Nottingham, UK. J. Antimicrob. Chemother. 65:1076-1077.
4. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
5. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement, M100-S20. CLSI, Wayne, PA.
6. KPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrob. Agents Chemother. 54:526-529.
7. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. 2010. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect. Dis. 10:43-50.
8. Falagas ME, Giannopoulou KP, Kokolakis GN, Rafailidis PI. 2008. Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin. Infect. Dis. 46:1069-1077. (Pubitemid 351589875)
9. Falagas ME, et al. 2010. Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int. J. Antimicrob. Agents 35:240-243.
10. Gautom RK. 1997. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J. Clin. Microbiol. 35:2977-2980. (Pubitemid 27452448)
11. Gupta K, et al. 2011. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 52:e103-e120.
12. Hsu MS, et al. 2011. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents. Int. J. Antimicrob. Agents. 37:276-278.
13. Hubka P, Boothe DM. 2011. In vitro susceptibility of canine and feline Escherichia coli to fosfomycin. Vet. Microbiol. 149:277-282.
14. Lei T, et al. 2010. Antimicrobial resistance in Escherichia coli isolates from food animals, animal food products and companion animals in China. Vet. Microbiol. 146:85-89.
15. Maraki S, et al. 2009. Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob. Agents Chemother. 53:4508-4510.
16. Mnif B, et al. 2010. Molecular characterization of addiction systems of plasmids encoding extended-spectrum β-lactamases in Escherichia coli. J. Antimicrob. Chemother. 65:1599-1603.
17. Oteo J, et al. 2009. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. J. Antimicrob. Chemother. 64:712-717.
18. Oteo J, Pérez-Vázquez M, Campos J. 2010. Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr. Opin. Infect. Dis. 23:320-326.
19. Patel SS, Balfour JA, Bryson HM. 1997. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 53:637-656. (Pubitemid 27145957)
20. Samonis G, et al. 2010. Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials. Future Microbiol. 5:961-970.
21. Seoane A, Sangari FJ, Lobo JM. 2010. Complete nucleotide sequence of the fosfomycin resistance transposon Tn2921. Int. J. Antimicrob. Agents 35:413-414.
22. CTX-M extended-spectrum β-lactamase genes in Escherichia coli isolates from pets and emergence of CTXM- 64 in China. Clin. Microbiol. Infect. 16:1475-1481.
23. Takahata S, et al. 2010. Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli. Int. J. Antimicrob. Agents. 35:333-337.
24. Villa L, GarcíA-Fernández A, Fortini D, Carattoli A. 2010. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J. Antimicrob. Chemother. 65:2518-2529.
25. Wachino J, Yamane K, Suzuki S, Kimura K, Arakawa Y. 2010. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob. Agents Chemother. 54: 3061-3064.
26. Warren JW, et al. 1999. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin. Infect. Dis. 29:745-758. (Pubitemid 30256361)
27. Xu H, Miao V, Kwong W, Xia R, Davies J. 2011. Identification of a novel fosfomycin resistance gene (fosA2) in Enterobacter cloacae from the Salmon River, Canada. Lett. Appl. Microbiol. 52:427-429.